Cargando…
Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations.
A correlation analysis was performed on 223 breast carcinomas to assess the relationships between gene amplification, karyotypic and clinicopathological features. Homogeneously staining region (HSR) is the most frequent form of amplification found in breast cancer. HSR-containing tumours accounted f...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063008/ https://www.ncbi.nlm.nih.gov/pubmed/9820183 |
_version_ | 1782137248770162688 |
---|---|
author | Bernardino, J. Gerbault-Seureau, M. Zafrani, B. Dericke, Y. Boudou, E. Magdelenat, H. Dutrillaux, B. |
author_facet | Bernardino, J. Gerbault-Seureau, M. Zafrani, B. Dericke, Y. Boudou, E. Magdelenat, H. Dutrillaux, B. |
author_sort | Bernardino, J. |
collection | PubMed |
description | A correlation analysis was performed on 223 breast carcinomas to assess the relationships between gene amplification, karyotypic and clinicopathological features. Homogeneously staining region (HSR) is the most frequent form of amplification found in breast cancer. HSR-containing tumours accounted for 60% of the cases. Although up to 40% of tumours with slightly altered karyotype contained HSRs, an excess of HSRs was found within the tumours whose karyotype showed the highest rates of rearranged chromosomes. HSRs were also found to be particularly frequent in small tumours of high histological grade and with a low expression of progesterone receptors. An excess of HSRs seems to be observed in younger patients, however, significant correlation could be demonstrated only for patients below 55 years and below 60 years, compared with older ones. With a 120-month follow-up for 152 patients, a significant association between the presence of HSRs and a shortened overall survival was observed. Altogether, the presence of HSRs appears to be a good indicator of poor prognosis. Further studies are needed to determine whether amplification of specific genes or cell ability to amplify is the most important parameter for tumour progression. IMAGES: |
format | Text |
id | pubmed-2063008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1998 |
publisher | Nature Publishing Group|1 |
record_format | MEDLINE/PubMed |
spelling | pubmed-20630082009-09-10 Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. Bernardino, J. Gerbault-Seureau, M. Zafrani, B. Dericke, Y. Boudou, E. Magdelenat, H. Dutrillaux, B. Br J Cancer Research Article A correlation analysis was performed on 223 breast carcinomas to assess the relationships between gene amplification, karyotypic and clinicopathological features. Homogeneously staining region (HSR) is the most frequent form of amplification found in breast cancer. HSR-containing tumours accounted for 60% of the cases. Although up to 40% of tumours with slightly altered karyotype contained HSRs, an excess of HSRs was found within the tumours whose karyotype showed the highest rates of rearranged chromosomes. HSRs were also found to be particularly frequent in small tumours of high histological grade and with a low expression of progesterone receptors. An excess of HSRs seems to be observed in younger patients, however, significant correlation could be demonstrated only for patients below 55 years and below 60 years, compared with older ones. With a 120-month follow-up for 152 patients, a significant association between the presence of HSRs and a shortened overall survival was observed. Altogether, the presence of HSRs appears to be a good indicator of poor prognosis. Further studies are needed to determine whether amplification of specific genes or cell ability to amplify is the most important parameter for tumour progression. IMAGES: Nature Publishing Group|1 1998-11 /pmc/articles/PMC2063008/ /pubmed/9820183 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Bernardino, J. Gerbault-Seureau, M. Zafrani, B. Dericke, Y. Boudou, E. Magdelenat, H. Dutrillaux, B. Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. |
title | Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. |
title_full | Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. |
title_fullStr | Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. |
title_full_unstemmed | Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. |
title_short | Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. |
title_sort | homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063008/ https://www.ncbi.nlm.nih.gov/pubmed/9820183 |
work_keys_str_mv | AT bernardinoj homogeneouslystainingregionsin223breastcarcinomascytogeneticandclinicopathologicalcorrelations AT gerbaultseureaum homogeneouslystainingregionsin223breastcarcinomascytogeneticandclinicopathologicalcorrelations AT zafranib homogeneouslystainingregionsin223breastcarcinomascytogeneticandclinicopathologicalcorrelations AT derickey homogeneouslystainingregionsin223breastcarcinomascytogeneticandclinicopathologicalcorrelations AT boudoue homogeneouslystainingregionsin223breastcarcinomascytogeneticandclinicopathologicalcorrelations AT magdelenath homogeneouslystainingregionsin223breastcarcinomascytogeneticandclinicopathologicalcorrelations AT dutrillauxb homogeneouslystainingregionsin223breastcarcinomascytogeneticandclinicopathologicalcorrelations |